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Interventions for infected and symptomatic walled-off pancreatic necrosis (WOPN) have undergone a paradigm shift away from open surgical
necrosectomy toward endoscopic intervention such as transmural drainage and necrosectomy. Recent multicenter studies and evidence-based guidelines
have suggested the safety and efﬁcacy of endoscopic transmural necrosectomy (ETN) for management of complicated WOPN. In consideration of the
inherent properties and the risks associated with this procedure, ETN should be performed by expert endoscopists who are well-versed in management of
necrotizing pancreatitis and supported by a special multidisciplinary team. Although there have been limited data to deﬁne the selection criteria and the
techniques regarding ETN, this comprehensive review focuses on the current indications, therapeutic outcomes, complications, and controversies of ETN
for management of WOPN.
Copyright  2014, Society of Gastrointestinal Intervention. Published by Elsevier. All rights reserved.
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Acute pancreatitis (AP) is a dynamic inﬂammatory process with
a benign clinical course and low mortality. However, 10–20% of
patients experience severe AP, which can result in an intense in-
ﬂammatory response, a prolonged hospital course, and variety of
local and systemic complications that carry a signiﬁcant risk of
morbidity and mortality.1–4 Necrosis of the pancreas itself is
deﬁned by nonenhancement of the parenchyma on dynamic
computed tomography scan, and approximately 5–10% of patients
with AP develop necrotizing pancreatitis. Necrosis of peripancre-
atic/pancreatic tissue can progress to liquefaction with subsequent
organization without epithelial lining, and eventual evolution into
a walled-off pancreatic necrosis (WOPN) over 4 weeks. This may be
related to secondary infection or symptomatic sterile necrosis.
Because the mortality rate of infected WOPN is as much as
approximately 39% compared to 15% of sterile WOPN, patients with
infection generally need to undergo an intervention, which has
shifted from primary open necrosectomy to a step-up approach.
Currently, step-up approach is a widely used treatment modality
consisting of percutaneous catheter drainage (PCD), endoscopic
transmural drainage (ETD), and endoscopic transmural necrosec-
tomy (ETN). Of these, ETN provides a targeted approach with a
reduction in the systemic inﬂammatory response and avoidance of
wound complications5; its use is increasingly widespread and nowDivision of Gastroenterology, Department of Internal Medicine, Gachon University Gil Medic
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we aim to determine the risk and beneﬁts of ETN for management
of necrotizing pancreatitis.Indications and strategies of intervention for WOPN
The primary indications for intervention in WOPN are similar
regardless of different intervention routes, such as endoscopic,
percutaneous, or surgical approach. The indications for interven-
tion in WOPN are as follows: (1) clinical suspicion or documented
infected WOPN with clinical deterioration; (2) ongoing organ fail-
ure in the several weeks after the onset of acute pancreatitis; (3)
symptomatic sterile WOPN including intractable pain, persistent
unwellness, ongoing gastrointestinal obstruction; and (4) discon-
nected pancreatic duct syndrome with WOPN.
Among various treatment modalities, surgical debridement,
either open or laparoscopic, may be associated with prolonged re-
covery, the need for repeat operations, external ﬁstula, and
abdominal wall hernias.6,7 Percutaneous debridement techniques
have been used as an alternative to operative management; how-
ever, these methods are not universally successful and additional
combination treatment is required.8–10 Endoscopic interventions,
such as ETD and ETN, have also been introduced in an effort to
overcome the aforementioned limitations; however, there are some
problems of accessibility and complication. Therefore, combinational Center, Incheon, Korea
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have recently been advocated. Endoscopic or percutaneous
drainage is ﬁrst recommended, and followed, if necessary, by
endoscopic or minimally invasive surgical necrosectomy. As a tar-
geted minimally invasive approach, ETN with mechanical
debridement was demonstrated to be an efﬁcacious and repro-
ducible technique with an acceptable safety proﬁle.11,12 The ideal
goal of ETN is excision of all dead and devitalized pancreatic and
peripancreatic tissue while preserving a viable functioning
pancreas, and controlling surgery related complications.
Overview of ETN
Necrotizing pancreatitis is a dynamic disease process that
evolves in local and systemic inﬂammation; consequently, endo-
scopic/percutaneous drainage alone often proves inadequate, and
additional endoscopic/surgical necrosectomy is required. The
optimal time for intervention of necrotizing pancreatitis is impor-
tant in order to reduce the occurrence of procedure related com-
plications, and it should be delayed by approximately 4 weeks after
the onset of pancreatitis, when vascular inﬂammation has
decreased, organization of the process has occurred, and delinea-
tion of live from dead tissue is complete. At this point, the retro-
peritoneal inﬂammatory response decreases and the necrotic areas
are demarcated from the surrounding viable tissue, which may
permit deﬁnitive endoscopic debridement.
Endoscopic interventions require proximity to the gastroduo-
denal lumen and WOPN, whereas percutaneous drainage may be
suitable for collections distant from the gut lumen and those with
less demarcation. Necrosis closely adhering to the posterior gastric
wall or medial duodenal wall is considered an ideal access route for
ETN; thus it is typically performed via a transgastric or trans-
duodenal approach. Under conscious sedation or anesthesia, a
puncture site is identiﬁed by locating a bulge into the gastroin-
testinal lumen using endoscopic ultrasound or visual assessment.
The ﬂuid collection is then entered, a sample of ﬂuid is aspirated
and cystenterostomy is created using wire-guided balloon dilators
up to 15–20 mm. Once the entry site is established, direct endo-
scopic debridement using endoscopic accessories, including snare,
baskets, and stone retrieval balloons, can be performed using a
conventional upper or water-jet endoscope. When ETN extends
into the fat of the mesocolon or small bowel mesentery, meticulous
care should be taken to avoid vascular injury, particularly to the
colic, superior, or inferior mesenteric vessels. After mechanical
removal of necrotic debris, large-bore double pigtail plastic stents
or a fully covered self-expandable metallic stent (SEMS) are inser-
ted into the cavity; a nasocystic tube may occasionally be placed for
postinterventional lavage. ETD can be performed during the index
procedure, but it is usually repeated on a regular basis until theFig. 1. Sequential endoscopic images showing walled off pancreatic necrosis (WOPN) cavity.
material; and (C) clean cavity after endoscopic necrosectomy.cavity is clean by direct visualization. Asmany as 3–10 sessionsmay
be necessary for complete debridement of the necrotic cavity;
however, the number of sessions depends on disease severity
(Fig. 1).Outcomes of endoscopic intervention
Endoscopic interventions for WOPN carry signiﬁcant additive
risks, and there are a few comparative data to document increased
success. Published studies of ETD and ETN are summarized in
Table 1.5,11–23 The Dutch Pancreatitis Group compared endoscopic
intervention (n ¼ 10) and surgical necrosectomy (n ¼ 10), and
showed that ETN reduced the proinﬂammatory response as well as
the composite clinical end point compared with surgical
necrosectomy.5 Factors that predict failure of endoscopic therapy
have not been well studied. A major determinant for the feasibility
of ETN is the location of the target collection and other risk factors
for failure of endoscopic intervention are the size of the necrotic
cavity (>15 cm), deep retroperitoneal extension, presence of dia-
betes mellitus, and comorbid conditions. Early aggressive adjuvant
therapy, such as PCD with or without sinus tract endoscopy or
video-assisted retroperitoneal debridement, in addition to endo-
scopic treatment, was required in patients with more extensive
necrotic debris, severe pancreatic duct disruption, or deep retro-
peritoneal necrotic extension.17 In cases of inaccessible necrotic
collections, a variety of other minimally invasive retroperitoneal
approaches, including PCD, sinus tract endoscopy, and video-
assisted retroperitoneal debridement procedure may be either
preferable or serve as adjuncts to endoscopic therapy.
Several novel approaches were recently introduced. First, the
multigateway approach uses more than one transmural entry site
created in order to facilitate rapid drainage in large (>80 mm)
symptomatic WOPN.24 One tract may serve as a channel for irri-
gation, whereas the other acts as an exit conduit for drainage of
necrotic contents.25 Second, esophageal fully covered SEMS has
been used for drainage of peripancreatic/pancreatic collec-
tions26,27; however, potential stent migration and uncertainty
regarding cost-effectiveness preclude widespread adoption in
clinical practice. Third, a novel type of antimigration SEMS for
cystenterostomy has been developed.28,29 These stents have a wide
lumen (16 mm diameter), allowing insertion of the endoscope
through the stent lumen for direct necrosectomy. In addition, novel
methods including hydrogen peroxide, vacuum sponge, and newly
developed grasping type of scissors for debridement are under
continuous investigation.30–32 Although their advantages and
safety are unclear compared to conventional methods, further
studies using newly developed devices and accessories for endo-
scopic necrosectomy are anticipated.(A) Initial ﬁnding after entry into complicated WOPN; (B) net snare removal of necrotic
Table 1 Clinical Outcomes of Endoscopic Transluminal Necrosectomy
Authors Patients (sterile/infected) Treatment modality Timing of intervention
(d after presentation)
Repeated interventions
(mean number)
Overall success
rate (%)
Complications (n) Mortality (n)
Bakker et al5 10 (0/10) PCD (1st)  ETN or VARD (2nd)
(vs. surgical necrosectomy)
59 3 10 (100) Pancreatic ﬁstula: 1
Others: 1
1 (10)
Gardner et al11 104 (64/40) ETN 63 3 95 (91) Major bleeding: 2
Minor bleeding: 19
Retrogastric perforation: 2
Pneumoperitoneum: 3
Air embolism: 1
5 (4.8)
Yasuda et al12 57 (0/57) ETN 50 5 43 (75) Major bleeding: 5
Perforation: 3
Air embolism: 1
6 (11)
Charnley et al13 13 (2/11) ETN 27 4 9 (69) NA 2 (15)
Escourrou et al14 13 (0/13) ETN  PCD (2 case) 28 1.8 13 (100) Bleeding: 3
Infection: 3
0
Hocke et al15 30 (0/30) ETN NA 2.7 27 (90) Bleeding, infection and ﬁstula: 10% 2 (6.6)
Mathew et al16 6 (0/6) ETN 42 0 6 (100) None 0
Papachristou et al17 53 (27/26) ETN  ETD  transpapillary stenting  PCD 49 3 43 (81) Bleeding: 9
Gallbladder puncture: 1
Stent migration: 2
3 (6)
Schrover et al18 8 (0/8) ETN 33 4 6 (75) Bleeding: 1
Pneumoperitoneum: 1 (fatal)
1 (12.5)
Seewald et al19 13 (0/13) ETN  transpapillary stenting NA 7 11 (85) NA 0
Voermans et al20 25 (6/19) ETN 84 2 23 (92) Major bleeding: 1 (operation)
Minor bleeding: 8
Perforation: 1 (operation)
0
Rische et al21 31 (7/24) ETN  transpapillary stenting NA 4 26 (83) Perforation of colon: 2
Stent dislocation to jejunum: 1
Major bleeding: 1 (fatal)
3 (9.6)
Ross et al22 15 (6/9) PCD (1st) + ETN (2nd) 29 1.4 15 (100) Infection: 1 0
Seifert et al23 93 (43/50) ETN 43 6.2 75 (81) Bleeding: 13
Perforation: 5
Fistula: 2
Infection: 1
Air embolism: 2
7 (7.5)
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A complication rate of ETN of up to approximately 30% has
been reported. In a recent systematic review including >1100
endoscopic necrosectomy procedures in 260 patients, procedure-
related morbidity rate was 27% and all-cause mortality rate was
5%.33 Bleeding is the most common complication and it may
occur during the index puncture or direct debridement of the
necrotic material. Sometimes, incidental mechanical injury of
retroperitoneal vessels such as the portal vein may result in a
drastic hemorrhage requiring emergent angiography or even
surgery. Perforation, another severe complication, might occur
during initial cystenterostomy, repeated dilation of the access
route, or disruption of the cavity wall. In general, surgical
management is required in many cases of perforation however,
Gardner et al11 reported successful nonoperative management of
ﬁve patients with perforation. In addition, many complications,
including infection of necrotic materials, air embolism, gall-
bladder puncture, stent migration, ﬁstula, and bowel obstruction
may occur during ETN. Among them, air embolism, which is
likely from dissection of insufﬂated air through exposed retro-
peritoneal vessels, may sometimes lead to fatal consequences.
Carbon dioxide is now very strongly recommended for air
insufﬂation during ETN, as it theoretically minimizes the chance
of air embolism.
ETN is the one of the most aggressive endoscopic interventions;
avoidance of all complications is impossible. Therefore, the most
important thing is the early recognition of these potential life-
threatening complications, and endoscopists should immediately
take an appropriate action for them in collaboration with inter-
ventional radiology and surgery.
ETD and ETN are regarded as important therapeutic procedures
formanagement of complicated and symptomaticWOPN; however,
many controversies remain. Contrary to opinion with regard to
preference of ETD or ETN, several reports have suggested the pos-
sibility of treatment of WOPN without formal drainage, either by
antibiotics alone or more commonly by use of selective percuta-
neous drainage. Mouli et al34 recently published a meta-analysis
involving 324 patients, which showed that primary nonoperative
management of infected necrosis without necrosectomy was suc-
cessful in 64% of cases and was associated with a lower mortality
and obviated the need for surgical necrosectomy. However, it re-
mains unclear as to which patients with WOPN can be safely and
effectively managedwith or without any forms of intervention, and
which method is better for management of cases. Considering the
high likelihood of success with ETD or transpapillary pancreatic
stent placement (in properly selected patients) alone, combined
procedures should probably be limited to special situations in order
to minimize complications.
Moreover, it is still not known whether endoscopic ultra-
sound is necessary in every initial puncture for cystenterostomy
and whether the optimal strategy involves a step-up approach
with initial drainage followed by on-demand ETN versus
scheduled ETN. It is also unclear whether necrosectomy, once
started, should be carried to completion in every case. In addi-
tion, there is uncertainness of optimal timing, number of ses-
sions, and completeness of endoscopic debridements, and we do
not have knowledge of the optimal interval between sessions
and how to remove the necrotic tissue. In terms of medical
devices for drainage and debridement, there is a lack of dedi-
cated instruments available for necrosectomy, many of which are
borrowed from other endoscopic applications. In addition, the
optimal stent for cystenterostomy also remains unsettled,
although the trend seems to be toward increasingly large tissue-
apposition-type removable SEMS.Conclusion
As a targeted minimally invasive approach, ETN with mechan-
ical debridement was suggested to be an efﬁcacious and repro-
ducible technique with an acceptable safety proﬁle. Despite the
possibility of severe procedure related complications, including
perforation, hemorrhage, infection, and air embolism, ETN with
mechanical debridement is regarded as a primary therapeutic
method for complicated and symptomatic WOPN. Considering the
inherent properties and the procedure related risks, ETN should be
performed by experienced interventional endoscopists who are
well-versed in management of necrotizing pancreatitis at special-
ized centers, and the optimal treatment should be tailored to the
individual patient by a multidisciplinary approach including a
gastroenterologist, interventional radiologist, and surgeon. Given
the complexity and risk associated with ETN, speciﬁc comprehen-
sion of pathogenesis of necrotizing pancreatitis, specialized
training of interventional endoscopic techniques and multidisci-
plinary approach to patients are essential to improving the thera-
peutic outcomes of complicated WOPN.
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